Erik Stites is a Nephrology physician affiliated with University of Colorado Denver. OpenAlex indexes 26 publications with 753 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12605 E 16th Ave
Aurora, CO 800452545
Telephone
720-848-0000Provider last certified this registry record 16 Jul 2024.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lilly USA, LLCProgram year20251 payment
- Alexion Pharmaceuticals, Inc.Program year20251 payment
- Invivyd IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
49.6%Calcium channel blocker14.7%Amlodipine Besylate100%Part D≥26 patientsStatin13%Atorvastatin Calcium100%Part D≥28 patients+ 4 more classes in this area
Metabolism & gastrointestinal
26.7%Corticosteroid24.2%Prednisone100%Part D≥48 patientsProton pump inhibitor2.5%Pantoprazole Sodium100%Part D<11 patientsAnti-infectives
8.5%Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor5.8%Valganciclovir Hcl100%Part D≥13 patientsShort-acting sulfonamides2.7%Sulfamethoxazole-Trimethoprim100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Induction of immune tolerance in living related human leukocyte antigen–matched kidney transplantation: A phase 3 randomized clinical trial
American Journal of Transplantation
2025 - Differential in Kidney Graft Years on the Basis of Solitary Kidney, Simultaneous Liver–Kidney, and Kidney-after-Liver Transplants
Clinical Journal of the American Society of Nephrology
2023 - Untangling the Clinical and Methodological Assessment of Risks Associated With BK Nephropathy
Kidney International Reports
2023 - MDR-101-MLK Update: Operational Immune Tolerance Achieved in Living Related HLA-Matched Kidney Transplant Recipients
Journal of the American Society of Nephrology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Nanette Santoro, MD
University of Colorado Denver
Gary Larsen, MD
University of Colorado Denver
Jonathan Gutman, MD
University of Colorado Denver
Lindsay Boyers, MD
University of Colorado Denver
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”